News
3h
Chowhound on MSNMyths About Garlic You Thought Were TrueGarlic tastes divine, but something that packs so much punch is bound to have plenty of myths surrounding it. We're here to ...
Hospitalists working in behavioral health centers face unique challenges, including limited resources and complex patient ...
A 19-year-old woman with a history of depression and anxiety symptoms was admitted to the hospital because of seizure, ...
Nucleic acid therapies offer targeted treatment for genetic diseases, but delivery remains a key hurdle. Explore how advances ...
The title of physician conferred a certain cachet when Dr. Jack Sternberg, a retired medical oncologist, entered medicine.
Alnylam is to file its givosiran with regulators to treat a form of the blood disease porphyria, applying its gene silencing technology to the condition for the first time, following supportive ...
Insights from analysts' 12-month price targets are revealed, presenting an average target of $357.7, a high estimate of $404.00, and a low estimate of $325.00. Marking an increase of 10.61%, the ...
Market Wrap Clinuvel (CUV) Shares in biopharmaceutical company Clinuvel have recently benefited from positive preliminary results in its phase three porphyria trial. Updated Dec 22, 2009 Joyce ...
Urine colour varies from light to dark yellow. It depends on hydration levels. Certain foods and medications can alter urine colour. Beetroot, carrots, and vitamin B supplements are examples. Blood, ...
Danish drugmaker Novo Nordisk must like what it has seen in its two-year-old alliance with gene-silencing specialist Dicerna Pharma – it has just agreed to acquire the biotech for $3.3 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results